Founded
29 Jun 2005
Address
Vivo Ventures LLC
575 High Street
Suite 201
Palo Alto, CA 94301
United States
Phone
Website
Industry
VCID: 30821
Profile
Corporate information
Registration country
Investment activity status
Active investor
Funds managed
| Fund | Type | Vintage |
|---|---|---|
| Vivo Ventures Fund VII LP | Venture | |
| Vivo Ventures VII Affiliates Fund LP | Venture |
Team
Current employees
![[node:title] photo](/sites/default/files/styles/icon/public/default_images/icon-person.png?itok=8SSzz6Wf "[node:title] photo"){kind=icon}
|
Albert Cha | ||
|
|
Edgar G Engleman | ||
|
|
Frank Kung |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
SentreHEART Inc A medical device company that has developed catheter-based solutions to address unmet clinical needs. |
United States | 1 Jun 2012 | Series C Initial investment. Round participant. Active |
|
|
|
Ceptaris Therapeutics Inc Specialty pharmaceuticals company. |
United States | 1 Jun 2012 | Series D Active |
|
|
|
AirXpanders A medical device company that has developed the AeroForm tissue expander. |
United States | 1 Jan 2012 | Series D Active |
|
|
|
Rempex Pharmaceuticals Inc Rempex Pharmaceuticals, Inc. is a San Diego-based pharmaceutical company. |
United States | 1 Nov 2011 | Series B Initial investment. Round participant. Active |
|
|
|
Revance Therapeutics Inc Develops and commercializes therapeutic products for treating chronic disease and age-related changes to skin and soft tissue. |
United States | 1 Jan 2010 1 Jun 2011 |
Venture |
|
|
|
Essentialis Inc Developing a novel therapy for the treatment of dyslipidemia. |
United States | 1 Oct 2010 | Series B |
|
|
|
TRIA Beauty Inc |
United States | 1 Sep 2010 31 Dec 2008 |
Venture |
|
|
|
Vicept Therapeutics Inc |
United States | 1 Jun 2010 | Series A |
|
|
Neomend Inc A biomedical device company, engages in the development and commercialization of surgical wound healing products |
United States | 1 Jan 2010 | Series D Active |
|
|
|
Eiger BioPharmaceuticals A biopharmaceutical company focused on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. |
United States | 1 Feb 2009 | Series A |
|
|
|
APT Pharmaceuticals Inc A pharmaceutical company focused on repurposing well-characterized drugs for under-served populations. |
United States | 1 Sep 2008 | Series A Initial investment. Round participant. Active |
|
|
|
InteKrin Therapeutics Inc Biopharmaceutical company focused on developing and commercializing breakthrough therapeutics for neuroendocrine, metabolic, and immune disorders.. |
United States | 1 Aug 2008 | Series C Active |
|
|
|
CAPNIA Inc |
United States | 1 Apr 2008 | Series C |
|
|
|
Avanir Pharmaceuticals Inc A biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. |
United States | 1 Apr 2008 | N/A |
|
|
|
Carbylan BioSurgery Inc |
United States | 1 Nov 2007 | Series B |
|
|
|
Transcept Pharmaceuticals Inc |
United States | 1 Mar 2007 1 Oct 2005 |
Series D |
|
|
|
Biodel Inc A biopharmaceutical company focused on the development and commercialization of treatments for diabetes |
United States | 1 Aug 2006 | Series B |